We are pleased to share with you our 2023 Annual Report. Although the Lymphedema Advocacy Group is now in its 14th year of existence, this is the first time we have assembled a formal annual report.
As such, the document does not merely highlight our work in 2023. It also looks back over all our efforts and accomplishments over the last 13 years, while also looking ahead to our goals for 2024 and beyond.
The Lymphedema Advocacy Group will continue to focus on all aspects of insurance coverage and reimbursement for lymphedema-related supplies and treatment, as our primary goal of improving patients’ access to care remains central to our mission.
However, with the Lymphedema Treatment Act now signed into law and the new Medicare coverage implemented, we are able to place additional focus on improving education and awareness.
For example, as shared in our last newsletter, we recently collaborated with the National Organization for Rare Disorders (NORD) to help them update their information page about Primary Lymphedema.
We are also working on creating separate handouts for patients, providers, and suppliers, with more extensive information for each audience. In the meantime, we hope you are finding our all-purpose one-pager about the new coverage helpful.
More work lies ahead, and we’ll be sure to let you know when your advocacy can make a difference once again. Donations to support our continued efforts are always deeply appreciated. Thank you for your continued engagement!
Heather Ferguson
Founder & Executive Director
Lymphedema Advocacy Group
LymphedemaTreatmentAct.org
 |
